Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: A thrombogenic mechanism for the antiphospholipid syndrome

Journal of Autoimmunity

Volumn 15, Issue 2, 2000, Pages 107-111

  Rand, Jacob H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Annexin V; Antiphospholipid antibody syndrome; Endothelium; Lupus anticoagulant; Placenta; Pregnancy loss; Thrombosis

Indexed keywords

LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; COMPLEX FORMATION; FETOPLACENTAL UNIT; HUMAN; IMMUNOASSAY; PATHOGENESIS; PLACENTA; PRIORITY JOURNAL; RECURRENT ABORTION; THROMBOGENESIS; THROMBOSIS;

EID: 0033826136     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0410     Document Type: Article

References (42)

1. The antiphospholipid syndrome
2. The anticardiolipin syndrome
3. The antiphospholipid antibody syndrome
4. Biologically false positive serological tests for syphilis: Type, incidence, and cause
5. Natural history of systemic lupus erythematosus: Approach to its study through chronic biologic false positive reactors
6. Lupus anticoagulants
7. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test
8. Acquired inhibitors of blood coagulation
9. Thrombosis in systemic erythematosus despite circulating anticoagulants
10. Hypergammaglobulinemia, circulating anticoagulant and biologic false-positive Wassermann reaction
11. Monoclonal immunoglobulin M lambda coagulation inhibition with phospholipid specificity. Mechanism of a lupus anticoagulant
12. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
13. The lupus anticoagulant/antiphospholipid syndrome
14. Lupus anticoagulants/antiphospholipid-protein antibodies: The great imposters
15. Antiphospholipid antibodies and venous thromboembolism
16. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population
17. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies
18. Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1
19. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles
20. Protein terminology tangle
21. 'Annexinopathies' - A new class of disease
22. Distinct annexin subfamilies in plants and protists diverged prior to animal annexins and from a common ancestor
23. Placental anticoagulant proteins: Isolation and comparative characterization of four members of the lipocortin family
24. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids
25. The annexins and exocytosis
26. Displacement of factor Va by annexin V
27. Three-dimensional structure of membrane-bound annexin V. A correlative electron microscopy-X-ray crystallography study
28. Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis
29. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and in vitro regulation
30. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast
31. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation
32. Pregnancy loss in the antiphospholipid-antibody syndrome - A possible thrombogenic mechanism
33. Placental anticoagulant protein-I: Measurements in extracellular fluids and cells of the hemostatic system
34. Annexin V is critical in the maintenance of murine placental integrity
35. Immunohistochemical study of annexin V expression in placentae of preeclampsia
36. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion
37. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi
38. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: A 'lupus procoagulant' phenomenon
39. A possible solution to the paradox of the 'lupus anticoagulant' antiphospholipid antibodies accelerate thrombin generation by inhibiting annexin-V
40. Antiphospholipid antibodies reduce annexin-V and accelerate coagulation on cell membranes: Mechanistic studies with a monoclonal antiphospholipid antibody
41. Human monoclonal antiphospholipid antibodies displace annexin-V from phospholipid bilayers and accelerate thrombin generation